Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Micrus Endovascular Corporation (NASDAQ: MEND) announced today that its stockholders approved a proposal to adopt the merger agreement which provides that Micrus is to become a...
Standard & Poor's Announces Change to U.S. Index PR Newswire NEW YORK, Sept. 14 NEW YORK, Sept. 14 /PRNewswire/ -- Monolithic Power Systems, Inc. (Nasdaq: MPWR) will replace Micrus Endovascular...
Micrus Endovascular Corporation (Nasdaq:MEND) today reported financial results for the three months ended June 30, 2010. Micrus reported total revenues of $24.6 million for...
The Law Office of Joseph Klein is investigating the Board of Directors of Micrus Endovascular Corporation (“Micrus” or the “Company”) (NasdaqGM: MEND) for possible breaches of...
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Micrus Endovascular Corporation (NASDAQ:...
The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Cash...
Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Micrus Endovascular Corporation (“Micrus Endovascular” or...
Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Micrus...
Kendall Law Group, a national securities firm led by a former federal judge Joe Kendall, is investigating Micrus Endovascular Corp. (NASDAQ:MEND) for shareholders in...
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/mend) is investigating potential claims against the board of directors of Micrus Endovascular Corporation ("Micrus" or the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
